What is the equity of Glaukos this year?
Glaukos has equity of 461.77 M USD this year.
Glaukos Equity 2024
Glaukos Equity
461.77 M USD
Ticker
GKOS
ISIN
US3773221029
WKN
A14VCK
In 2024, Glaukos's equity was 461.77 M USD, a -12.87% increase from the 530 M USD equity in the previous year.
Glaukos Aktienanalyse
What does Glaukos do?
Glaukos Corp is a medical technology company specializing in developing devices and therapies for treating eye diseases. It was founded in 1998 by employees of the ophthalmology center at the University of California San Francisco. The company focuses on utilizing new technologies and therapies to improve the vision quality of patients. They have developed innovative products for diagnosing and treating various eye conditions, including glaucoma. Their core business involves manufacturing and distributing medical devices for glaucoma treatment, such as the iStent implant. They have also partnered with other institutions to advance research and development in the field of ophthalmology. In 2018, Glaukos Corp acquired the German manufacturer Markt II Medical, expanding their product offerings for a wider range of eye diseases. In summary, Glaukos Corp is an innovative medical technology company that aims to enhance patients' vision quality while minimizing the risks of eye surgery. Glaukos ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Glaukos's Equity
Glaukos's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Glaukos's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Glaukos's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Glaukos's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Glaukos’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Glaukos stock
What was the equity of Glaukos compared to the previous year?
The equity of Glaukos has increased/decreased by -12.87% decreased compared to the previous year.
What impact does a high equity have on investors of Glaukos?
A high equity is advantageous for investors of Glaukos as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Glaukos?
A low equity can be a risk for investors of Glaukos, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Glaukos affect the company?
An increase in equity of Glaukos can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Glaukos affect the company?
A reduction in equity of Glaukos can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Glaukos?
Some factors that can affect the equity of Glaukos include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Glaukos so important for investors?
The equity of Glaukos is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Glaukos take to change the equity?
To change equity, Glaukos can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Glaukos pay?
Over the past 12 months, Glaukos paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Glaukos is expected to pay a dividend of 0 USD.
What is the dividend yield of Glaukos?
The current dividend yield of Glaukos is .
When does Glaukos pay dividends?
Glaukos pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Glaukos?
Glaukos paid dividends every year for the past 0 years.
What is the dividend of Glaukos?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Glaukos located?
Glaukos is assigned to the 'Health' sector.
Wann musste ich die Aktien von Glaukos kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Glaukos from 10/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/6/2024.
When did Glaukos pay the last dividend?
The last dividend was paid out on 10/6/2024.
What was the dividend of Glaukos in the year 2023?
In the year 2023, Glaukos distributed 0 USD as dividends.
In which currency does Glaukos pay out the dividend?
The dividends of Glaukos are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Glaukos
Our stock analysis for Glaukos Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Glaukos Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
